Article
Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits.
Journal of molecular medicine (Berlin, Germany) - 1 May 2005
Nielsen Eva-Maria D, Hansen Lars, Stissing Trine, Yanagisawa Keiko, Borch-Johnsen Knut, Poulsen Pernille, Vaag Allan, Hansen Torben, Pedersen Oluf
Abstract excerpt
CDK4 is involved in the regulation of body weight, pancreatic beta-cell proliferation, insulin responsiveness, and diabetes pathogenesis. CDK4 activity is inhibited by CDKN1C, which is regulated by insulin. In addition, CDKN1C plays an important role in beta-cell proliferation and is involved in the pathogenesis of the Beckwith-Wiedemann syndrome, a disorder characterized by neonatal hyperinsulinaemic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
